Caribou Biosciences’ $304 Million Initial Public Offering

Shearman & Sterling advised the underwriters in the offering.Caribou Biosciences, Inc. executed its initial public offering of 19 million shares of common stock at a public offering…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now